Clinical Medicine Insights: Endocrinology and Diabetes Liraglutide in Adults with Type 2 Diabetes: Global perspective on Safety,
Clinical Medicine Insights: Endocrinology and Diabetes pioglitazone in the Treatment of Type 2 Diabetes: safety and Efficacy R
Clinical Medicine Insights: Endocrinology and Diabetes Use of parathyroid Hormone Assay after Thyroidectomy: A survey of Us and
![Treatment of type 2 diabetes: challenges, hopes, and anticipated successes - The Lancet Diabetes & Endocrinology Treatment of type 2 diabetes: challenges, hopes, and anticipated successes - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/fd476cd3-0fd0-4380-abda-4520153d6a7b/gr1.jpg)
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes - The Lancet Diabetes & Endocrinology
![Frontiers | COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course Frontiers | COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course](https://www.frontiersin.org/files/Articles/649525/fendo-12-649525-HTML/image_m/fendo-12-649525-g001.jpg)
Frontiers | COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
![COVID-19 and diabetes mellitus: from pathophysiology to clinical management | Nature Reviews Endocrinology COVID-19 and diabetes mellitus: from pathophysiology to clinical management | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-00435-4/MediaObjects/41574_2020_435_Fig1_HTML.png)
COVID-19 and diabetes mellitus: from pathophysiology to clinical management | Nature Reviews Endocrinology
![New insights into the older hypoglycemic agents in type 2 diabetes therapy - Cao - 2020 - Journal of Diabetes - Wiley Online Library New insights into the older hypoglycemic agents in type 2 diabetes therapy - Cao - 2020 - Journal of Diabetes - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4e615ee2-9d42-44c9-9e2d-6e7646a99180/1753-0407.13096.fp.png)
New insights into the older hypoglycemic agents in type 2 diabetes therapy - Cao - 2020 - Journal of Diabetes - Wiley Online Library
![Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle? Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?](https://www.mdpi.com/medicina/medicina-58-00472/article_deploy/html/images/medicina-58-00472-g001.png)
Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
![Microvascular Outcomes of Pediatric-Onset Type 1 Diabetes Mellitus: A Single-Center Observational Case Reviews in Sana'a, Yemen – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free Microvascular Outcomes of Pediatric-Onset Type 1 Diabetes Mellitus: A Single-Center Observational Case Reviews in Sana'a, Yemen – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free](https://cyberleninka.org/viewer_images/743957/f/1.png)
Microvascular Outcomes of Pediatric-Onset Type 1 Diabetes Mellitus: A Single-Center Observational Case Reviews in Sana'a, Yemen – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
![Open Access Endocrinology on Twitter: "Submit your #research to our open special collection on #peptide based therapies in #diabetes. https://t.co/8yjJUFaAc1 @SAGEClinMed @LinnemannLab @PattersonSteve1 #OpenAccess #FOAMed #Insulinanalogues, #Incretins ... Open Access Endocrinology on Twitter: "Submit your #research to our open special collection on #peptide based therapies in #diabetes. https://t.co/8yjJUFaAc1 @SAGEClinMed @LinnemannLab @PattersonSteve1 #OpenAccess #FOAMed #Insulinanalogues, #Incretins ...](https://pbs.twimg.com/media/D3xuA2yW0AI2pAc.jpg)
Open Access Endocrinology on Twitter: "Submit your #research to our open special collection on #peptide based therapies in #diabetes. https://t.co/8yjJUFaAc1 @SAGEClinMed @LinnemannLab @PattersonSteve1 #OpenAccess #FOAMed #Insulinanalogues, #Incretins ...
Clinical Medicine Insights: Endocrinology and Diabetes Type 1 Diabetes Mellitus Associated with pegylated Interferon-a plus Rib
![Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - eBioMedicine Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c56e4504-697d-479f-9704-b18594efe698/gr1_lrg.jpg)
Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - eBioMedicine
Clinical Medicine Insights: Endocrinology and Diabetes The Clinical Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Agon
![Japanese Clinical Practice Guideline for Diabetes 2016 - Haneda - 2018 - Journal of Diabetes Investigation - Wiley Online Library Japanese Clinical Practice Guideline for Diabetes 2016 - Haneda - 2018 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f0886903-4948-4a6a-92a8-90adb74d2a90/jdi12810-fig-0004-m.jpg)